FINADYNE® Transdermal Pour-on Solution Now Available for Mastitis to Improve Animal Care16 October 2015
ITALY - MSD Animal Health today announced FINADYNE® Transdermal (flunixin meglumine) pour-on solution can now be used to reduce pyrexia associated with acute mastitis. This claim adds to the already proven efficacy to reduce pyrexia associated with Bovine Respiratory Disease.
“This additional claim for FINADYNE Transdermal pour-on allows for a more convenient way to relieve animals from fever, improve respiratory and depression scores associated with Bovine Respiratory Disease (BRD) and mastitis,” said Siddartha Torres, Technical Director, MSD Animal Health.
“FINADYNE Transdermal is making its mark as the world’s first non-parasiticide cattle product available with a transdermal route of administration and builds on the legacy of FINADYNE as the pioneer injectable non-steroidal anti-inflammatory drug.”
The company will showcase FINADYNE Transdermal pour-on at the European Buiatrics Congress in Rome, Italy October 14-16 with special emphasis during a 90 minute symposium on Thursday October 15.
During the session, attendees will learn more about the science behind the claim and the practical benefits of using it to control inflammation. Additionally, FINADYNE Transdermal will be featured in a series of interviews and discussions on the extremely informative Studio Bovine during and after the Congress.
FINADYNE Transdermal goes to work quickly and has been demonstrated to reduce fever as early as four hours after administration. Studies show the reduction of inflammation in the udder is also rapid, alleviating the swelling pain associated with acute mastitis, a significant factor in cow comfort. The innovative technology of FINADYNE Transdermal allows for rapid absorption of flunixin through the skin and into the bloodstream. The efficient administration means there is no need for additional labor, head gates or restraint commonly associated with injectable administration, which translates to reduced cost per treatment.
This new approach to reducing fever in cattle is in alignment with industry efforts to continuously improve animal care. The pour-on application requires less handling, resulting in less stress on animals and leading to inherent health and wellness advantages. It also offers the added benefit of needle-free administration, with no injection site lesions and a higher-value end product.
To learn more about FINADYNE® Transdermal Pour-on, visit www.msd-animal-health.com
|TheCattleSite News Desk||More MSD Animal Health News|